Home › Astrocytoma › Tennessee › Nashville
Astrocytoma clinical trials in Nashville, TN
3 studies for Astrocytoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
- Vanderbilt University Medical Center, Nashville
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- Vanderbilt University/Ingram Cancer Center, Nashville
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Vanderbilt-Ingram Cancer Center, Nashville
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- Chicago, IL9 studies
- New York City, NY9 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- Columbus, OH6 studies
- San Francisco, CA6 studies
- Washington, DC6 studies
- Durham, NC6 studies
- Seattle, WA6 studies
- Salt Lake City, UT5 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.